PRGF + atazanavir

PRGF + atazanavir is a combination of two agents. Atazanavir is an antiretroviral drug classified as a protease inhibitor, used in the treatment of HIV infection. It works by inhibiting the HIV-1 protease enzyme, thereby preventing viral replication and reducing viral load in patients with HIV[2][4]. PRGF does not correspond to any recognized pharmaceutical agent or standard abbreviation in the context of antiretroviral therapy or other established drug classes; its identity remains unclear based on available data. Atazanavir is typically administered with other antiretrovirals and sometimes boosted with pharmacokinetic enhancers such as ritonavir or cobicistat[2][4]. The combination described here appears to be non-standard, and there are no known approved products or clinical guidelines supporting the use of "PRGF" together with atazanavir.